PD-1:PD-L inhibitory pathway affects both CD4+ and CD8+ T cells and is overcome by IL-2

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

European Journal of Immunology

Topics

Biology

Biochemistry

Cancer Oncology

Immunology

Endocrinology

Show all topics

DOI

10.1002/1521-4141(200203)32:3<634::aid-immu634>3.0.co;2-9